A Pilot Study on the Effect of Privigen Against Graft Loss: Interventional Study of Kidney Transplant Recipients at Risk for Graft Loss Through Antibody-mediated Rejection
Phase of Trial: Phase III
Latest Information Update: 12 May 2016
At a glance
- Drugs Immune globulin (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms InAuGuRAL
- 12 May 2016 Last checked against ClinicalTrials.gov record.
- 09 May 2016 Planned End Date changed from 1 Mar 2017 to 1 Feb 2019.
- 09 May 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Feb 2019.